8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Efficacy, safety and tolerability of bosentan in Chinese patients with pulmonary arterial hypertension

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Bosentan has an established role in the management of pulmonary arterial hypertension (PAH). This clinical trial assessed the benefits of bosentan in the Chinese population.

          Related collections

          Author and article information

          Journal
          The Journal of Heart and Lung Transplantation
          The Journal of Heart and Lung Transplantation
          Elsevier BV
          10532498
          February 2010
          February 2010
          : 29
          : 2
          : 150-156
          Article
          10.1016/j.healun.2009.09.020
          20113907
          3b4e3052-f142-4918-bfda-556b3a720823
          © 2010

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article